English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The use of teleneurology was determined by factors such as a great demand of neurological follow-up services for epileptic patients and the fact that most neurologists reside in the main cities. Overall Objective: to evaluate patient satisfaction rates with teleneurology and the human and technical resources needed for the implementation and evaluation of this consultation system. Methods: a pilot trial was conducted between January and March 2012. The inclusion criteria were: patients older than 18 years with confirmed diagnosis of epilepsy and an informed consent. The sample was divided into the standard face to face consultation group (GI) and the teleconsultation group (GIi). Results:GI included 15 patients and 2 were excluded. In GIi, only 7 met the inclusion criteria out of 26 patients. The patient satisfaction rate in GI was 92% and in GII 72%. Discussion: GII evidenced high satisfaction rates; the trial defines the human and technical replication requirements for this system. Conclusions: telemedicine is a feasible strategy for improving the scope of neurology services in patients with confirmed diagnosis of epilepsy for it has a high level of acceptability. Further trials in a larger population for longer periods must be conducted to confirm cost effectiveness and patient and neurologist satisfaction rates for this activity.

Teleneurología para el seguimiento de pacientes epilépticos prueba piloto en el hospital de San José. Bogotá DC, Colombia